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Summary
Hereditary spastic paraplegia is a genetically and phe-
notypically heterogeneous disorder. Both pure and com-
plicated forms have been described, with autosomal
dominant, autosomal recessive, and X-linked inheri-
tance. Various loci (SPG1–SPG6) associated with this
disorder have been mapped. Here, we report linkage
analysis of a large consanguineous family affected with
autosomal recessive spastic paraplegia with age at onset
of 25–42 years. Linkage analysis of this family excluded
all previously described spastic paraplegia loci. A ge-
nomewide linkage analysis showed evidence of linkage
to chromosome 16q24.3, with markers D16S413 (max-
imum LOD score 3.37 at recombination fraction [v] of
.00) and D16S303 (maximum LOD score 3.74 at v 
). Multipoint analysis localized the disease gene in.00
the most telomeric region, with a LOD score of 4.2.
These data indicate the presence of a new locus linked
to pure recessive spastic paraplegia, on chromosome
16q24.3, within a candidate region of 6 cM.
Introduction
Hereditary spastic paraplegias (HSPs) are a group of
inherited disorders characterized by progressive spastic-
ity and weakness of lower limbs (Fink et al. 1996). The
most relevant pathological feature is degeneration of the
corticospinal tracts and of the posterior columns. Epi-
demiological studies on HSP reported a prevalence ratio
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of in Cantabria, Spain (Polo et al. 1993),59.6# 10
and in Molise, Italy (Filla et al. 1992). HSP52.7# 10
has been divided into pure and complicated forms. Pure
HSP is defined clinically by spastic gait, hyperreflexia,
and Babinski sign. Minimal clumsiness of upper limbs,
urinary symptoms, lower-limb deep sensory loss, slight
distal amyotrophy, and pes cavus may be present. Com-
plicated forms of HSP have additional features, such as
mental retardation, pigmentary retinal degeneration, op-
tic atrophy, extrapyramidal features, cerebellar signs, se-
vere muscular atrophy, severe sensory neuropathy, ich-
thyosis, and skin depigmentation.
Autosomal dominant (AD), autosomal recessive (AR),
and X-linked recessive varieties of HSP have been rec-
ognized. Pure AD-HSP is genetically heterogeneous. Loci
for AD-HSP have been identified on chromosomes 14q
(SPG3, MIM 182600; Hazan et al. 1993), 2p (SPG4,
MIM 182601; Hazan et al. 1994; Hentati et al. 1994b),
and 15q (SPG6, MIM 600363; Fink et al. 1995). A locus
for pure AR-HSP has been found on chromosome 8q
(SPG5A, MIM 270800; Hentati et al. 1994a). The ex-
istence of one AR-HSP family for whom this locus was
excluded (Hentati et al. 1994a) indicated the existence
of additional, as yet unidentified AR-HSP loci (SPG5B,
MIM 600146). Mutations have been found for X-linked
uncomplicated HSP (Xp22; SPG2, MIM 312920) in the
proteolipoprotein gene (Kobayashi et al. 1994; Saugier-
Veber et al. 1994), allelic to the Pelizaeus-Merzbacher
disease locus (Gencic et al. 1989). Jouet et al. (1994)
described mutation of the L1CAM gene in a complicated
form of X-linked HSP (SPG1, MIM 312900) in X-linked
hydrocephalus patients and in cases of mental retarda-
tion, aphasia, shuffling gait, and adducted thumbs syn-
drome, defining these three syndromes as allelic
disorders.
Here we report the identification of a large pedigree
affected by AR-HSP. We demonstrate that, in this family,
the disease does not segregate with the previously re-
ported loci. We performed a genomewide search and
found that, in this pedigree, the disease locus is linked
to marker loci on chromosome 16q24.3. Mutation at
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Figure 1 Pedigree of the AR-HSP family and haplotype analysis of markers (listed from top to bottom) D16S511, D16S3037, D16S520,
D16S3048, D16S413, D16S3023, and D16S303.
this newly identified locus could account both for fam-
ilies in which HSP is not linked to previously described
loci and for sporadic HSP patients.
Subjects and Methods
Pedigree Assessment
The family was identified during an epidemiological
survey performed in Molise, a region in southern Italy
(Filla et al. 1992). The family is highly consanguineous,
since two brothers married two sisters, all being first
cousins. All living members of the pedigree were per-
sonally examined by the authors (A.F., G.D.M., and
R.M.), except individual IV-5 (fig. 1). He was reported
as being affected but was unavailable for examination
because he had moved to Australia. Individuals were
considered affected if they presented lower-limb hyper-
reflexia associated with at least one of the following:
increased tone, pyramidal weakness, or extensor plantar
response.
Clinical Features
The main clinical findings in our patients are shown
in table 1. Mean age at onset  SD was years30 8
(range 25–42 years). A reliable age at onset was not
obtained for patient IV-12. Abnormal gait was the pre-
senting symptom in all cases, and it was associated with
leg pains in patient IV-10. Weakness and extensor plan-
tar response were absent in the patient (IV-9) with the
shortest disease duration. Vibration sense was frequently
decreased in lower limbs. Hypernasal and slowed speech
were present in two patients and dysphagia in one. Uri-
nary urgency was present in three patients (IV-4, IV-9,
and IV-10), scoliosis and pes cavus in two patients (IV-
10 and IV-11), and pale optic disk in two patients (IV-
4 and IV-11). Cerebellar and extrapyramidal signs were
absent in all cases. Magnetic resonance imaging of the
brain and spinal cord, performed on three patients, was
normal in two (patients IV-9 and IV-10) and showed
vascular lesions in the right frontal cortex of patient IV-
12. Peripheral nerve conduction studies performed on
patient IV-9 showed slight axonal neuropathy. Disease
progression was slow. All patients were able to walk
independently, with the exception of the oldest patient
(IV-4), who needs constant assistance.
Linkage Analysis
A 20-ml venous blood sample was obtained from five
patients and seven healthy relatives who gave their in-
formed consent. DNA was extracted from peripheral
blood lymphocytes, in accordance with procedures de-
scribed elsewhere (Miller et al. 1988). Linkage to chro-
mosome 8 (SPG5A) was tested by use of D8S260 and
D8S166 markers. Linkage to AD-HSP loci was tested
by use of D2S352 (SPG4), D14S269 (SPG3), and
D15S128 (SPG6) markers. Oligonucleotide sequences
and PCR conditions were as described elsewhere. PCR
products were separated by electrophoresis on 7% de-
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Table 1
Clinical Findings
Clinical Feature IV-4 IV-9 IV-10 IV-11 IV-12
Age (years) 60 46 49 46 43
Age at onset (years) 25 42 27 26 ?
Spastic gait     
Dysarthria     
Dysphagia     
Upper limbs:
Increased tone     
Tendon reflexes Brisk Brisk Brisk Brisk Brisk
Weakness     
Wasting     
Decreased vibration
sense     
Lower limbs:
Increased tone     
Tendon reflexes Brisk Brisk Clonus Brisk Brisk
Weakness     
Wasting     
Decreased vibration
sense     
Plantar response Ext Normal Ext Ext Ext
NOTE.—Aminus sign () indicates absence; a plus sign () indicates
presence, to various degrees (, mild; , moderate; and , se-
vere); and a question mark (?) indicates unknown. Ext  extensor.
Table 2
LOD Scores of Selected 16q Dinucleotide Markers
MARKER
LOD SCORE AT v 
.00 .01 .05 .10 .20 .30 .40
D16S511  3.87 1.31 .40 .18 .25 .15
D16S3037  1.61 2.05 2.01 1.59 .99 .35
D16S520  1.98 2.42 2.39 1.97 1.38 .69
D16S3048  .88 1.33 1.32 1.04 .68 .31
D16S413 3.37 3.30 3.03 2.69 1.96 1.20 .47
D16S3023 3.26 3.20 2.96 2.65 1.99 1.29 .61
D16S303 3.74 3.68 3.41 3.06 2.30 1.48 .61
naturant polyacrylamide gels. After electrophoresis, gels
were stained by means of silver staining. The size of
alleles was determined by comparison to M13 DNA
sequence.
The fluorescence-labeled set of markers used in the
genomewide scan consists of 358 highly polymorphic
dinucleotide markers (Gyapay et al. 1994; Dib et al.
1996) that are evenly distributed throughout the genome
at an average distance of 10 cM. All of the available
pedigree members have been genotyped by use of the
whole marker set. Two-point linkage analysis was per-
formed on a SUN Ultra-SPARC workstation with use of
the MLINK feature of the LINKAGE package (Lathrop
et al. 1985). Because of computing constraints deriving
from the consanguinity loops present in this family, mul-
tipoint linkage analysis was performed with use of the
GENEHUNTER software (Kruglyak et al. 1996). For
linkage calculations, AR-HSP was modeled as an AR
trait with complete penetrance, and the mutation rate
was assumed to be 105. Recombination frequencies
were assumed to be equal between males and females.
Published marker-allele frequencies were used for these
calculations.
Results
Exclusion of Linkage with Previously Described Loci
We performed linkage analysis with the previously
described AR form (SPG5A) locus on chromosome 8 by
using D8S260 and D8S166 markers. LOD score values
were negative (D8S260: maximum LOD score 19.85
at a recombination fraction [v] of .00; D8S166: maxi-
mum LOD score 13.85 at ). These results in-v  .00
dicated that our pedigree was not linked to chromosome
8 and that a different gene must be responsible for the
observed phenotype.
Therefore, we concluded that this family can be con-
sidered to have a new form of AR-HSP not linked to
chromosome 8. As the next step, we tested this pedigree
for linkage with markers of the AD-HSP forms (SPG3,
SPG4, and SPG6). Negative LOD scores were obtained
with D2S352 (SPG4), D14S269 (SPG3), and D15S128
(SPG6) (data not shown).
Genomewide Scanning for the New AR-HSP
On the basis of our exclusion mapping data, we con-
sidered this pedigree for genomewide linkage mapping.
The probability of detecting significant linkage was
tested, by means of simulation analysis on 400 simulated
pedigrees, by SLINK 2.5v software (Ott 1989), on a SUN
Ultra-SPARC workstation. The analysis was performed
under the assumptions of AR inheritance, complete pen-
etrance, marker heterozygosity .75, and disease fre-
quency . The maximum LOD score at51# 10 v 
was 4.01, with 48% conditional probability of de-.02
tecting significant LOD score values.
A genomewide search was performed on all of the
available pedigree members. Two loci suggestive of link-
age (LOD score 11.0) were identified on chromosomes
16 and 17, and the marker density was locally increased
by testing all pedigree members with two additional
markers, ∼5 cM telomeric and ∼5 cM centromeric, for
each candidate locus. The candidate locus on chromo-
some 17 was clearly excluded from linkage (data not
shown). The chromosome 16 locus gave a LOD score
value of 2.42 at for marker D16S520, whichv  .05
maps on the telomeric region of the long arm of chro-
mosome 16, and was confirmed by flanking markers
(maximum LOD score at : D16S413, 3.37;v  .00
D16S3023, 3.26; and D16S303, 3.74).
As reported in the two-point LOD score table (table
2) and in the multipoint linkage graph (fig. 2) showing
a multipoint LOD score value of 4.2, we have localized
a new AR-HSP locus in the telomeric region of chro-
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Figure 2 Multipoint LOD score analysis of the distal 16q region.
Distances are in centimorgansHald from D16S511, which was taken
arbitrarily as 0.
mosome 16 (16q24.3), in an area of ∼6 cM. The 13
members of the IV generation are the offspring of two
consanguineous first-cousin marriages (fig. 1); among
them, all affected patients participating in the study
share a common homozygous haplotype for markers
D16S413, D16S3023, and D16S303 (1-1-1). Patient IV-
4 shows a recombination between loci D16S3048 and
D16S413, allowing us to narrow the candidate area to
the telomeric region of 16q.
Two additional uncomplicated AR-HSP families, both
excluded from linkage to the chromosome 8 locus, were
tested for linkage to chromosome 16q24.3 markers. One
of these pedigrees is compatible with linkage to this new
locus, even though the LOD score value is not signifi-
cant, whereas in the other family the linkage with 16q
telomeric markers is excluded (data not shown).
Discussion
We mapped a new locus responsible for AR-HSP to
chromosome 16. AR forms of pure spastic paraplegia
are less frequent than AD forms (Harding 1981; Polo
et al. 1993). The phenotype does not differ clearly from
that of AD-HSP. Besides spastic paraplegia, the following
have been reported: urinary disturbances, sensory loss,
pes cavus, and upper-limb clumsiness. Harding (1981)
suggested genetic heterogeneity within AR-HSP on the
basis of a different age at onset, reporting two families
with childhood onset and one with adult onset. Polo et
al. (1993) reported onset within 20 years in six patients
from two families. In the five families reported by Hen-
tati et al. (1994a), the ages at disease onset were 1–20
years. Molecular analysis has been performed only in
the latter families, and, in four of them, the disease locus
was mapped to the pericentric region of chromosome 8.
The highest LOD score value was 8.77, with no recom-
bination with the marker D8S260. Nonetheless, linkage
to this region was excluded in one family.
In the present paper, we describe a large inbred family
with a pure form of AR-HSP. Linkage to the previously
described locus for AR-HSP on chromosome 8 was ex-
cluded. Since there are several examples of disorders in
which AD and AR forms are allelic (OMIM 1996; see
disorders and MIM numbers listed in the Introduction
section), we have also excluded linkage with markers of
the AD-HSP forms (SPG3, SPG4, and SPG6). These re-
sults suggest that the genetic locus involved in HSP in
our family is different from all of those previously de-
scribed in other forms of HSP.
The genetic heterogeneity of AR-HSP, which resulted
from previously reported data and from our exclusion
mapping data, induced us to consider this pedigree for
a genomewide linkage mapping study. A new AR-HSP
locus was identified on a region spanning ∼6 cM on the
chromosome 16q terminus (16q24.3).
The family we report here is characterized by age at
onset 125 years; this is different from the majority of
the previously reported families, in which age at onset
is !20 years, as usually occurs in AR disorders. There
are no other clinical peculiarities that clearly distinguish
our family. However, the most severely affected patients
showed dysarthria and dysphagia, symptoms that are
not usually found in HSP. Du¨rr et al (1994) reported
dysarthria in 2 of 70 patients with AD-HSP. The small
number of patients does not allow us to establish
whether these features characterize this particular form
of AR-HSP. Other families need to be tested for this new
HSP locus to establish whether this pedigree carries a
private mutation or whether our data establish a new
genetic class of AR-HSP. However, further genetic het-
erogeneity of pure AR-HSP is expected, since we have
excluded chromosome 8 and chromosome 16 loci from
linkage to HSP in one pedigree.
Several partial and complete transcripts have been
mapped to the telomeric region of chromosome 16q,
where the gene involved in this new form of HSP must
lie. These include the gene responsible for Fanconi ane-
mia (Fanconi Anaemia/Breast Cancer Consortium
1996), the cellular adhesion regulator molecule gene,
which is involved in the suppression of tumor invasion
(Pullman and Bodmer 1992), and the melanocyte-stim-
ulating hormone receptor (Mountjoy et al. 1992). De-
tailed screening of the partial transcript sequences (ex-
pressed sequence tag, National Center for Biotechnology
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Information) mapped in the critical region is being per-
formed to identify the gene possibly involved in the neu-
ronal degeneration of HSP.
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